End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,365 KRW | +3.44% | -11.19% | +1.04% |
2023 | Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index | CI |
2022 | Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. | CI |
Sales 2018 | - | Sales 2019 | - | Capitalization | 90.48M 123B |
---|---|---|---|---|---|
Net income 2018 | 3M 4.06B | Net income 2019 | 23M 31.16B | EV / Sales 2018 * | - |
Net cash position 2018 * | - 0 | Net cash position 2019 * | - 0 | EV / Sales 2019 * | - |
P/E ratio 2018 * |
-
| P/E ratio 2019 * |
-
| Employees | - |
Yield 2018 * |
-
| Yield 2019 * |
-
| Free-Float | 87.57% |
1 day | +3.44% | ||
1 week | -11.19% | ||
Current month | +15.32% | ||
1 month | +80.75% | ||
3 months | +4.55% | ||
6 months | +33.90% | ||
Current year | +1.04% |
Managers | Title | Age | Since |
---|---|---|---|
Ki-Sub Lee
CEO | Chief Executive Officer | 73 | 07-06-14 |
Jae-Moon Lee
PSD | President | 66 | - |
In-Chul Kim
PRN | Corporate Officer/Principal | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ki-Sub Lee
CEO | Chief Executive Officer | 73 | 07-06-14 |
Jae-Moon Lee
PSD | President | 66 | - |
1st Jan change | Capi. | |
---|---|---|
+1.04% | 90.48M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.11% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- A284620 Stock